Kaempferitrin attenuates unilateral ureteral obstruction‐induced renal inflammation and fibrosis in mice by inhibiting NOX4‐mediated tubular ferroptosis

Fuente: Wiley Open Access
Saved in:
Bibliographic Details
Main Authors: Jianchun Li, Jieke Yang, Qianwen Xian, Hongwei Su, Yufang Ni, Li Wang
Format: Artículo Open Access
Published: Wiley 2024
Subjects:
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867016027714355200
author Jianchun Li
Jieke Yang
Qianwen Xian
Hongwei Su
Yufang Ni
Li Wang
author_facet Jianchun Li
Jieke Yang
Qianwen Xian
Hongwei Su
Yufang Ni
Li Wang
Jianchun Li
Jieke Yang
Qianwen Xian
Hongwei Su
Yufang Ni
Li Wang
collection Wiley Open Access
contents Kaempferitrin attenuates unilateral ureteral obstruction‐induced renal inflammation and fibrosis in mice by inhibiting NOX4‐mediated tubular ferroptosis Jianchun Li Jieke Yang Qianwen Xian Hongwei Su Yufang Ni Li Wang Phytotherapy Research AbstractTubular ferroptosis significantly contributes to renal inflammation and fibrosis, critical factors in chronic kidney disease (CKD). This study aims to investigate Kaempferitrin, a potent flavonoid glycoside from Bauhinia forficata leaves, renowned for its anti‐inflammatory and antitumor effects, and to elucidate its potential mechanisms in mitigating inflammation and fibrosis induced by tubular ferroptosis. The study investigated Kaempferitrin's impact on tubular ferroptosis using a unilateral ureteral obstruction (UUO) model‐induced renal inflammation and fibrosis. In vitro, erastin‐induced ferroptosis in primary tubular epithelial cells (TECs) was utilized to further explore Kaempferitrin's effects. Additionally, NADPH oxidase 4 (NOX4) transfection in TECs and cellular thermal shift assay (CETSA) were conducted to identify Kaempferitrin's target protein. Kaempferitrin effectively improved renal function, indicated by reduced serum creatinine and blood urea nitrogen levels. In the UUO model, it significantly reduced tubular necrosis, inflammation, and fibrosis. Its renoprotective effects were linked to ferroptosis inhibition, evidenced by decreased iron, 4‐hydroxynonenal (4‐HNE), and malondialdehyde (MDA) levels, and increased glutathione (GSH). Kaempferitrin also normalized glutathione peroxidase 4 (GPX4) and Solute Carrier Family 7 Member 11(SLC7A11) expression, critical ferroptosis mediators. In vitro, it protected TECs from ferroptosis and consistently suppressed NOX4 expression. NOX4 transfection negated Kaempferitrin's antiferroptosis effects, while CETSA confirmed Kaempferitrin‐NOX4 interaction. Kaempferitrin shows promise as a nephroprotective agent by inhibiting NOX4‐mediated ferroptosis in tubular cells, offering potential therapeutic value for CKD. 10.1002/ptr.8191 http://onlinelibrary.wiley.com/termsAndConditions#vor
doi_str_mv 10.1002/ptr.8191
format Artículo Open Access
id wiley_oa_10_1002_ptr_8191
institution Wiley Open Access
license_str_mv http://onlinelibrary.wiley.com/termsAndConditions#vor
publishDate 2024
publisher Wiley
record_format wiley_oa
spellingShingle Kaempferitrin attenuates unilateral ureteral obstruction‐induced renal inflammation and fibrosis in mice by inhibiting NOX4‐mediated tubular ferroptosis
Jianchun Li
Jieke Yang
Qianwen Xian
Hongwei Su
Yufang Ni
Li Wang
Phytotherapy Research
Kaempferitrin attenuates unilateral ureteral obstruction‐induced renal inflammation and fibrosis in mice by inhibiting NOX4‐mediated tubular ferroptosis Jianchun Li Jieke Yang Qianwen Xian Hongwei Su Yufang Ni Li Wang Phytotherapy Research AbstractTubular ferroptosis significantly contributes to renal inflammation and fibrosis, critical factors in chronic kidney disease (CKD). This study aims to investigate Kaempferitrin, a potent flavonoid glycoside from Bauhinia forficata leaves, renowned for its anti‐inflammatory and antitumor effects, and to elucidate its potential mechanisms in mitigating inflammation and fibrosis induced by tubular ferroptosis. The study investigated Kaempferitrin's impact on tubular ferroptosis using a unilateral ureteral obstruction (UUO) model‐induced renal inflammation and fibrosis. In vitro, erastin‐induced ferroptosis in primary tubular epithelial cells (TECs) was utilized to further explore Kaempferitrin's effects. Additionally, NADPH oxidase 4 (NOX4) transfection in TECs and cellular thermal shift assay (CETSA) were conducted to identify Kaempferitrin's target protein. Kaempferitrin effectively improved renal function, indicated by reduced serum creatinine and blood urea nitrogen levels. In the UUO model, it significantly reduced tubular necrosis, inflammation, and fibrosis. Its renoprotective effects were linked to ferroptosis inhibition, evidenced by decreased iron, 4‐hydroxynonenal (4‐HNE), and malondialdehyde (MDA) levels, and increased glutathione (GSH). Kaempferitrin also normalized glutathione peroxidase 4 (GPX4) and Solute Carrier Family 7 Member 11(SLC7A11) expression, critical ferroptosis mediators. In vitro, it protected TECs from ferroptosis and consistently suppressed NOX4 expression. NOX4 transfection negated Kaempferitrin's antiferroptosis effects, while CETSA confirmed Kaempferitrin‐NOX4 interaction. Kaempferitrin shows promise as a nephroprotective agent by inhibiting NOX4‐mediated ferroptosis in tubular cells, offering potential therapeutic value for CKD. 10.1002/ptr.8191 http://onlinelibrary.wiley.com/termsAndConditions#vor
title Kaempferitrin attenuates unilateral ureteral obstruction‐induced renal inflammation and fibrosis in mice by inhibiting NOX4‐mediated tubular ferroptosis
topic Phytotherapy Research
url https://onlinelibrary.wiley.com/doi/10.1002/ptr.8191